Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

October 28, 2015

Primary Completion Date

September 17, 2020

Study Completion Date

June 25, 2021

Conditions
Bone MetastasisCancer Pain
Interventions
DRUG

Tanezumab

Subcutaneous study treatment (tanezumab 20 mg or matched placebo) dosed at 8 week intervals.

Trial Locations (89)

3165

Monash Medical Centre, East Bentleigh

3168

Monash Medical Centre, Clayton

3500

Landesklinikum Krems, Krems

3529

CRU Hungary Ltd., MISEK Hematology Department-CRU Co., Miskolc

CRU Hungary Ltd., MISEK-CRU, Miskolc

3541

Nuhr Medical Center, Senftenberg

4400

Josa Andras Hospital, Clinical Research Department, Nyíregyháza

Szabolcs-Szatmar-Bereg Megyei Korhazak es Egyetemi Oktatokorhaz, Nyíregyháza

8000

Help-MR Diagnosztika Kft., Székesfehérvár

8582

Veszprem Megyei Tudogyogyintezet Farkasgyepu, Farkasgyepű

10408

Clinical Trial Pharmacy, National Cancer Center, Goyang-si

Imaging Facilities, National Cancer Center, Goyang-si

National Cancer Center, Goyang-si

28006

Hospital Universitario de la Princesa, Madrid

28050

Hospital La Moraleja, Madrid

Hospital Universitario HM Sanchinarro, Madrid

30100

Urocentrum Plzen Research Site s.r.o., Pilsen

42601

Keimyung University Dongsan Medical Center, Daegu

52621

Chaim Sheba Medical Center, Ramat Gan

94001

DEMOMED s.r.o., Nové Zámky

100071

The Fifth Medical Center of PLA General Hospital, Beijing

150081

Harbin Medical University Cancer Hospital/Oncology Department, Harbin

200233

Shanghai Sixth People's Hospital, Shanghai

200385

SC Oncolab SRL, Craiova

230022

The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology, Hefei

300060

Tianjin Cancer Hospital, Tianjin

300166

S.C. Oncocenter Oncologie Clinica S.R.L., Timișoara

310022

Zhejiang Cancer Hospital, Hangzhou

400042

Daping Hospital, Research Institute of Surgery Third Military Medical University, Chongqing

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology/Cancer Center, Wuhan

430079

Hubei Cancer Hospital, Wuhan

450008

Henan Cancer Hospital/Respiration internal medicine, Zhengzhou

610041

Oncology Department, West China Hospital of Sichuan University, Chengdu

1834111

HaEmek Medical Center, Afula

3109601

Rambam Health Care Campus, Haifa

4800827

James Lind Centro de lnvestigacion del Cancer, Araucania

S2000KZE

Instituto de Oncologia de Rosario, Rosario

20560-120

INCA - Instituto Nacional do Cancer / Hospital do Cancer HCIII, Rio de Janeiro

98700-000

Associacao Hospital de Caridade de Ijui, Ijuí

88.301-220

Centro de Novos Tratamentos Itajai - Clinica de Neoplasias Litoral, Itajaí

14.784-400

Fundação Pio XII-Hospital de Cancer de Barretos, Barretos

17210-120

Centro de Ensino e Pesquisa da Fundacao Amaral Carvalho, Jaú

09060-650

Fundacao do ABC - Faculdade de Medicina do ABC - CEPHO, Santo André

09060-870

Fundacao do ABC-Faculdade de Medicina do ABC, Santo André

01509-900

Hospital AC Camargo_Fundacao Antonio Prudente, São Paulo

Hospital AC Camargo_Fundacao Antonio Prudente, São Paulo

03102-006

Centro de Pesquisa Clinica do IBCC - Instituto Brasileiro de Controle do Cancer, São Paulo

128 00

Vseobecna fakultni nemocnice v Praze, Fakultni poliklinika, Centrum pro lecbu bolesti, Prague

440-8510

National Hospital Organization Toyohashi Medical Center, Toyohashi

277-8577

National Cancer Center Hospital East, Kashiwa

373-8550

Gunma Prefectural Cancer Center, Ōta

663-8014

Nishinomiya Municipal Central Hospital, Nishinomiya

663-8501

The Hospital of Hyogo College of Medicine, Nishinomiya

840-8571

Saga-Ken Medical Centre Koseikan, Saga

152-8902

National Hospital Organization Tokyo Medical Center, Tokyo

42-500

Powiatowy Zespol Zakladow Opieki Zdrowotnej Oddzial Opieki Paliatywnej, Będzin

15-215

NZOZ Vitamed im. Edyty Jakubow, Bialystok

15-437

Poradnia Otropedyczno-Urazowa; Gabient RTG, Bialystok

41-250

Pracownia RTG Helimed, Czeladź

41-300

Niepubliczny Zaklad Opieki Zdrowotnej, Zespol Medyczno-Opiekunczy Alicja Kluczna, Dąbrowa Górnicza

80-208

Hospicjum im. Ks. Eugeniusza Dutkiewicza SAC w Gdansku, Gdansk

44-100

Stowarzyszenie Przyjaciol Chorych Hospicjum w Gliwicach NZOZ Hospicjum Milosierdzia Bozego, Gliwice

Stowarzyszenie Przyjaciol Chorych Hospicjum w Gliwicach, NZOZ Hospicjum Milosierdzia Bozego, Gliwice

86-300

Regionalny Szpital Specjalistyczny im. Dr. Wl.Bieganskiego, Oddzial Onkologii Klinicznej, Grudziądz

40-057

SCANiX Sp.z o.o, Katowice

40-060

"NZOZ Vegamed", Katowice

40-760

Helimed Diagnostic Imaging Sp. z o.o., Sp. komandytowa, Katowice

Helimed Diagnostic Imaging Sp. z.o.o., Sp. komandytowa, Katowice

40-872

Centrum Diagnostyki Obrazowej EPIONE, Katowice

20-064

NZOZ Neuromed M. i M. Nastaj Sp. P., Lublin

61-245

SK Przemienienia Panskiego UM im. Karola Marcinkowskiego w Poznaniu,, Poznan

02-781

Klinika Nowotworow Piersi i Chirurgii Rekonstrukcyjnej w Centrum Onkologii -Instytucie, Warsaw

02-801

Szpital LUX MED, Warsaw

011464

Spitalul Clinic C.F. 2 Bucuresti. Departament Oncologie, Sectia Medicala 2, Bucharest

833 10

Narodny onkologicky ustav, Bratislava

018 52

MUDr. Viliam Cibik, PhD, s.r.o., Pruské

012 07

Fakultna Nemocnica S Poliklinikou Zilina, Žilina

03722

Clinical Trial Pharmacy, Severance Hospital, Seoul

Imaging Facilities, Severance Hospital, Seoul

Severance Hospital, Yonsei University Health System, Seoul

06351

Samsung Medical Center, Seoul

03203

Hospital General Universitario de Elche Servicio de Farmacia, Elche

Hospital General Universitario de Elche, Elche

07800

Hospital Can Misses, Ibiza Town

03010

Hospital General Universitario de Alicante, Alicante

SW17 0QT

St George's University Hospitals NHS Foundation Trust, Tooting

EH16 4SA

NHS Lothian, Royal Infirmary of Edinburgh, Edinburgh

EH4 2XU

NHS Lothian, Western General Hospital, Edinburgh

NHS Lothian, Edinburgh

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Pfizer

INDUSTRY

NCT02609828 - Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy | Biotech Hunter | Biotech Hunter